| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/19/2009 | WO2009033282A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 03/19/2009 | WO2009033233A1 Novel p2x7 epitopes |
| 03/19/2009 | WO2009033212A1 The use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers |
| 03/19/2009 | WO2009017655A3 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof |
| 03/19/2009 | WO2009015336A3 Controlled release interferon drug products and treatment of hcv infection using same |
| 03/19/2009 | WO2009015063A3 Methods and compositions for treating fibrosis related disorders using il-17 antagonists |
| 03/19/2009 | WO2009013622A3 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
| 03/19/2009 | WO2009006548A3 Treatment for anxiety |
| 03/19/2009 | WO2009002456A3 Methods and compositions relating to progenitor cells |
| 03/19/2009 | WO2009000296A3 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 03/19/2009 | WO2008157593A3 Protein c for use in maintaining hemostasis |
| 03/19/2009 | WO2008157419A3 Immunogenic peptides of influenza virus |
| 03/19/2009 | WO2008146018A3 Drug delivery system comprising matrix metalloproteinase inhibitors |
| 03/19/2009 | WO2008132485A3 Mutants of interleukin- 1 receptor antagonist and uses thereof |
| 03/19/2009 | WO2008132224A3 Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
| 03/19/2009 | WO2008108808A3 Complexes derived from heterohybrid cells and uses thereof |
| 03/19/2009 | WO2008096276A3 Peptide inhibitors of metallo- ectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses |
| 03/19/2009 | WO2008065144A3 Galenic formulations of organic compounds |
| 03/19/2009 | WO2007047609A3 INHIBITION OF PLACENTA GROWTH FACTOR (PlGF) MEDICATED METASTASIS AND/OR ANGIOGENESIS |
| 03/19/2009 | WO2007011773A3 Reduction in myocardial infarction size |
| 03/19/2009 | WO2005101993A3 Metal-containing nanolayered composites, and applications thereof |
| 03/19/2009 | WO2005086684A3 Method for modulating, regulating and/or stabilizing angiogenesis |
| 03/19/2009 | WO2005076886A3 Prostasin substrates and inhibitors |
| 03/19/2009 | WO2005074556A3 Netrin compositions and methods of use thereof |
| 03/19/2009 | WO2005060667A3 Nucleic acid and amino acid sequences involved in pain |
| 03/19/2009 | US20090077681 Methods for Diagnosing and Treating Heart Disease |
| 03/19/2009 | US20090077679 Gene silencing by systemic rna interference |
| 03/19/2009 | US20090077677 Mammalian grainyhead transcription factors |
| 03/19/2009 | US20090076246 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 03/19/2009 | US20090076176 Prodrugs activated by plasmin and their use in cancer chemotherapy |
| 03/19/2009 | US20090076033 Method for treating atherosclerosis employing an aP2 inhibitor and combination |
| 03/19/2009 | US20090076023 Local Anesthetic Methods and Kits |
| 03/19/2009 | US20090075951 Methods and Reagents for the Treatment of Inflammatory Disorders |
| 03/19/2009 | US20090075924 antisense therapy; for diagnosis and treatment of atherosclerosis, hypercholesterolemia, or coronary artery disease |
| 03/19/2009 | US20090075907 Synthetic peptide amides |
| 03/19/2009 | US20090075906 Oligopeptides and compositions containing the oligopeptides |
| 03/19/2009 | US20090075905 Anticancer compounds and methods |
| 03/19/2009 | US20090075904 Protein Hydrolysate Enriched In Peptides Inhibiting DPP-IV And Their Use |
| 03/19/2009 | US20090075903 increases differentiation of high proliferative potential-stem and progenitor cells, colony forming cells-granulocyte, erythroid, macrophage, megakaryocyte cells, granulocyte-macrophage-colony forming cells, megakaryocyte-colony forming cells, T-lymphocytes; refractory anemia |
| 03/19/2009 | US20090075902 Inhibiting the signs of aging by inhibiting nf-kappa b activation |
| 03/19/2009 | US20090075901 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/19/2009 | US20090075900 Therapeutic agent for motor neuron disease |
| 03/19/2009 | US20090075899 Inhibiting collagen-induced platelet aggregation and activation with peptide variants |
| 03/19/2009 | US20090075898 Complement C3A Derived Peptides and Uses Thereof |
| 03/19/2009 | US20090075897 Peptides derived from the C2 domain of epsilon PKC and methods of use, thereof |
| 03/19/2009 | US20090075896 hypotensive polypeptide in dairy product food; milk proteins as inhibitor of angiotensin I-converting enzyme; treating cardiovascular disease |
| 03/19/2009 | US20090075895 Stabilised Solid Composition of Modified Factor VII |
| 03/19/2009 | US20090075893 Inhibition of Angiogenesis by Neutrophil Alpha-Defensins |
| 03/19/2009 | US20090075892 Synthetic pulmonary surfactant peptides |
| 03/19/2009 | US20090075891 Methods and dressings for sealing internal injuries |
| 03/19/2009 | US20090075890 Long lasting synthetic exendin-4 peptide conjugates and methods of use thereof |
| 03/19/2009 | US20090075889 Iren protein, its preparation and use |
| 03/19/2009 | US20090075888 Cardiovascular and Brain Cell Therapy Using Intracellular Ryanodine Receptor Modulation by the Estrogen Receptor Beta |
| 03/19/2009 | US20090075887 Treatment with Kallikrein Inhibitors |
| 03/19/2009 | US20090075886 Dendritic cell stimulatory factor |
| 03/19/2009 | US20090075885 Antitumor effect of mutant bik |
| 03/19/2009 | US20090075884 Human il-17f and other il-17f-related proteins and methods related thereto |
| 03/19/2009 | US20090075883 Compositions for the treatment of cancer, and methods for testing and using the same |
| 03/19/2009 | US20090075882 Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosis |
| 03/19/2009 | US20090075881 Fibrin gel for controlled release of pdgf and uses thereof |
| 03/19/2009 | US20090075880 Albumin Fusion Proteins |
| 03/19/2009 | US20090075879 Novel Peptide Compositions and the Use Thereof, in Particular, in the Preparation of Active Pharmaceutical Compositions Against the Hepatitis C Virus |
| 03/19/2009 | US20090075878 Methods for Generating and Screening Fusion Protein Libraries and Uses Thereof |
| 03/19/2009 | US20090075877 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 03/19/2009 | US20090075876 Altered insulin-like growth factor binding proteins |
| 03/19/2009 | US20090075875 Protection against lung fibrosis by up-regulating the function or expression of caveolin-1 |
| 03/19/2009 | US20090075874 Methods for construction and screening of libraries of chemokine variants |
| 03/19/2009 | US20090075873 Gastrin compositions and formulations, and methods of use and preparation |
| 03/19/2009 | US20090075872 Methods and means |
| 03/19/2009 | US20090075871 Modified Thioredoxin |
| 03/19/2009 | US20090075870 Deuterium-enriched caspofungin |
| 03/19/2009 | US20090075869 HCV NS3 protease inhibitors |
| 03/19/2009 | US20090075868 Synthetic peptide materials for joint reconstruction, repair and cushioning |
| 03/19/2009 | US20090075867 Triazine compounds and compositions thereof for the treatment of cancers |
| 03/19/2009 | US20090075866 Reducing hypotensive events experienced by normovolemic subject during surgery while under general anesthesia via modified hemoglobin |
| 03/19/2009 | US20090075865 Novel medicament for ameliorating dyskinesia |
| 03/19/2009 | US20090075864 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/19/2009 | US20090075863 Periosteal Tissue Grafts |
| 03/19/2009 | US20090075862 Method for providing glutamine |
| 03/19/2009 | US20090075861 Systems and methods of removing and managing heavy metals |
| 03/19/2009 | US20090075860 Transdermal absorption enhancer |
| 03/19/2009 | US20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof |
| 03/19/2009 | US20090075369 Angiostatin Fragments and Method of Use |
| 03/19/2009 | US20090075335 Self-assembling protein hydrogel with bio-active protein |
| 03/19/2009 | US20090075334 screening for a compound to change binding of ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; drug screening; used in treating HIV infection, cancer, and various other diseases and disorders |
| 03/19/2009 | US20090075327 Methods for improving secondary metabolite production in fungi |
| 03/19/2009 | US20090075303 Allo and Auto-Reactive T-Cell Epitopes |
| 03/19/2009 | US20090075297 Mammalian galanin receptors |
| 03/19/2009 | US20090075268 Glycoprotein for use in the treatment of hearing loss defects; Inner Ear Supporting Cell Antigen (IESCA) reactive with an autoantibody associated with AISNHL |
| 03/19/2009 | US20090075253 Bioreactive agents |
| 03/19/2009 | US20090074893 Antiviral peptides |
| 03/19/2009 | US20090074886 Gsk-3 inhibitors |
| 03/19/2009 | US20090074876 Peptide composition and a method of promoting cartilage formation |
| 03/19/2009 | US20090074871 Composition for filling bone defects |
| 03/19/2009 | US20090074870 Alteration of cell membrane for new functions |
| 03/19/2009 | US20090074865 Oral formulations of glycyl-2-methylprolyl-glutamate |
| 03/19/2009 | US20090074864 Novel antimicrobial peptides with heparin binding activity |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074850 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 03/19/2009 | US20090074847 Transport System In Biological Systems |